Nicolet Advisory Services’s Aethlon Medical AEMD Stock Holding History

Nicolet Advisory Services’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	-$2K	–	171
2019 Q3	$2K	Hold	1	–	–	﹤0.01%	165
2019 Q2	$4K	Buy	+1	New	+$6.7K	﹤0.01%	161

Other funds holding AEMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GEA

Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return

Nicolet Advisory Services's AEMD Position: Q4 2019 in Review

Nicolet Advisory Services sold out of Aethlon Medical (AEMD) in Q4 2019, closing a stake of 1 share — an estimated $2K sold.

Nicolet Advisory Services first reported a position in AEMD in Q2 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 9 funds tracked by Wall St. Rank hold AEMD as of Q4 2019.

Nicolet Advisory Services reported no remaining Aethlon Medical position as of Q4 2019 after selling out during the quarter.
Nicolet Advisory Services sold 1 Aethlon Medical share in Q4 2019, an estimated $2K.
Nicolet Advisory Services first reported a position in Aethlon Medical in Q2 2019 and held it in 2 quarters.
Nicolet Advisory Services's Aethlon Medical position peaked at $4K in Q2 2019.
9 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2019.

Based on Nicolet Advisory Services's 13F filing for Q4 2019, filed 23 Jan 2020.